The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Melanoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1970) · Cited by 24,983
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Self-citationThe blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Self-citationPD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Self-citationNivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
Self-citationMutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Self-citationTechnical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W.-J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,392
Self-citationHauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Self-citationCombined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Distinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Robert, C., Karaszewska, B., Schachter, J., Rutkowski, P., Mackiewicz, A., Stroiakovski, D., Lichinitser, M., Dummer, R., Grange, F., Mortier, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412690 · Cited by 2,701
Self-citationVitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationTumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
Self-citationBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Self-citationSurvival in BRAF V600-mutant advanced melanoma treated with vemurafenib
Sosman, J. A., Kim, K. B., Schuchter, L., Gonzalez, R., Pavlick, A. C., Weber, J. S., McArthur, G. A., Hutson, T. E., Moschos, S. J., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112302 · Cited by 2,156
Self-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Self-citationCardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Long, G. V., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Grob, J. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406037 · Cited by 1,899
Self-citationDe Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,890
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Huang, F. W., Hodis, E., Xu, M. J., Kryukov, G. V., Chin, L., & Garraway, L. A. (2013) · Science · doi:10.1126/science.1229259 · Cited by 1,816
TERT Promoter Mutations in Familial and Sporadic Melanoma
Horn, S., Figl, A., Rachakonda, P. S., Fischer, C., Sucker, A., Gast, A., Kadel, S., Moll, I., Nagore, E., Hemminki, K., et al. (2013) · Science · doi:10.1126/science.1230062 · Cited by 1,799
Self-citationRobert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W.-J., Gangadhar, T. C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60958-2 · Cited by 1,774
Self-citationA comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
Self-citationVitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Vieth, R. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.842 · Cited by 1,500
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., Puleo, C. A., Coventry, B. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310460 · Cited by 1,484
Mutations in GNA11 in Uveal Melanoma
Van Raamsdonk, C. D., Griewank, K. G., Crosby, M. B., Garrido, M. C., Vemula, S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,476
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
Harbour, J. W., Onken, M. D., Roberson, E. D. O., Duan, S., Cao, L., Worley, L. A., Council, M. L., Matatall, K. A., Helms, C., & Bowcock, A. M. (2010) · Science · doi:10.1126/science.1194472 · Cited by 1,462
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikakos, P. I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M. T., et al. (2011) · Nature · doi:10.1038/nature10662 · Cited by 1,454
Self-citationBRAF mutation predicts sensitivity to MEK inhibition
Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G., Basso, A., Ye, Q., Lobo, J. M., She, Y., Osman, I., et al. (2006) · Nature · doi:10.1038/nature04304 · Cited by 1,328
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266
Villanueva, J., Vultur, A., Lee, J. T., Somasundaram, R., Fukunaga-Kalabis, M., Cipolla, A. K., Wubbenhorst, B., Xu, X., Gimotty, P. A., Kee, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.023 · Cited by 1,259
Self-citationExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Systemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,188
Roesch, A., Fukunaga-Kalabis, M., Schmidt, E. C., Zabierowski, S. E., Brafford, P. A., Vultur, A., Basu, D., Gimotty, P., Vogt, T., & Herlyn, M. (2010) · Cell · doi:10.1016/j.cell.2010.04.020 · Cited by 1,158
Self-citationGershenwald, J. E., Thompson, W., Mansfield, P. F., Lee, J. E., Colome, M. I., Tseng, C.-H., Lee, J. J., Balch, C. M., Reintgen, D. S., & Ross, M. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.976 · Cited by 1,139
Self-citationParallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Su, F., Viros, A., Milagre, C., Trunzer, K., Bollag, G., Spleiss, O., Reis-Filho, J. S., Kong, X., Koya, R. C., Flaherty, K. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105358 · Cited by 1,038
Self-citationAcquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Shi, H., Hugo, W., Kong, X., Hong, A., Koya, R. C., Moriceau, G., Chodon, T., Guo, R., Johnson, D. B., Dahlman, K. B., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0642 · Cited by 982
Self-citationGermline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
McArthur, G. A., Chapman, P. B., Robert, C., Larkin, J., Haanen, J. B., Dummer, R., Ribas, A., Hogg, D., Hamid, O., Ascierto, P. A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70012-9 · Cited by 977
Self-citationThe Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Van Allen, E. M., Wagle, N., Sucker, A., Treacy, D. J., Johannessen, C. M., Goetz, E. M., Place, C. S., Taylor-Weiner, A., Whittaker, S., Kryukov, G. V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0617 · Cited by 912
Self-citationA review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Sun, C., Wang, L., Huang, S., Heynen, G. J. J. E., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S. M., et al. (2014) · Nature · doi:10.1038/nature13121 · Cited by 888
KIT as a Therapeutic Target in Metastatic Melanoma
Carvajal, R. D. (2011) · JAMA · doi:10.1001/jama.2011.746 · Cited by 888
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Abeni, D., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.015 · Cited by 842
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818
Reduced melanoma after regular sunscreen use: randomized trial follow-up
Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7078 · Cited by 799
Metastasis genes: A progression puzzle
Bernards, R., & Weinberg, R. A. (2002) · Nature · doi:10.1038/418823a · Cited by 798
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Self-citationGermline mutations in BAP1 predispose to melanocytic tumors
Wiesner, T., Obenauf, A. C., Murali, R., Fried, I., Griewank, K. G., Ulz, P., Windpassinger, C., Wackernagel, W., Loy, S., Wolf, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.910 · Cited by 725
NRAS mutation status is an independent prognostic factor in metastatic melanoma
Jakob, J. A., Bassett, R. L., Ng, C. S., Curry, J. L., Joseph, R. W., Alvarado, G. C., Rohlfs, M. L., Richard, J., Gershenwald, J. E., Kim, K. B., et al. (2012) · Cancer · doi:10.1002/cncr.26724 · Cited by 689
Self-citationRoesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.003 · Cited by 670
Self-citationMelanoma epidemiology and trends
Garbe, C., & Leiter, U. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.001 · Cited by 657
Self-citationCutaneous melanoma attributable to sunbed use: systematic review and meta-analysis
Boniol, M., Autier, P., Boyle, P., & Gandini, S. (2012) · BMJ · doi:10.1136/bmj.e4757 · Cited by 644
Shi, H., Moriceau, G., Kong, X., Lee, M.-K., Lee, H., Koya, R. C., Ng, C., Chodon, T., Scolyer, R. A., Dahlman, K. B., et al. (2012) · Nature Communications · doi:10.1038/ncomms1727 · Cited by 640
Self-citationErdmann, F., Lortet‐Tieulent, J., Schüz, J., Zeeb, H., Greinert, R., Breitbart, E. W., & Bray, F. (2013) · International Journal of Cancer · doi:10.1002/ijc.27616 · Cited by 627
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Bald, T., Quast, T., Landsberg, J., Rogava, M., Glodde, N., Lopez-Ramos, D., Kohlmeyer, J., Riesenberg, S., van den Boorn-Konijnenberg, D., Hömig-Hölzel, C., et al. (2014) · Nature · doi:10.1038/nature13111 · Cited by 623
Self-citationImmunohistochemical characteristics of melanoma
Ohsie, S. J., Sarantopoulos, G. P., Cochran, A. J., & Binder, S. W. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00891.x · Cited by 593
Tumor adaptation and resistance to RAF inhibitors
Lito, P., Rosen, N., & Solit, D. B. (2013) · Nature Medicine · doi:10.1038/nm.3392 · Cited by 585
Feng, X., Degese, M. S., Iglesias-Bartolome, R., Vaque, J. P., Molinolo, A. A., Rodrigues, M., Zaidi, M. R., Ksander, B. R., Merlino, G., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 563
Hauschild, A., Agarwala, S. S., Trefzer, U., Hogg, D., Robert, C., Hersey, P., Eggermont, A., Grabbe, S., Gonzalez, R., Gille, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7636 · Cited by 548
Self-citationEggermont, A. M., Spatz, A., & Robert, C. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60802-8 · Cited by 548
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Bastian, B. C. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104658 · Cited by 513
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Self-citationElevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
Montagut, C., Sharma, S. V., Shioda, T., McDermott, U., Ulman, M., Ulkus, L. E., Dias-Santagata, D., Stubbs, H., Lee, D. Y., Singh, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6787 · Cited by 508
Mitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., Guerrero, C. R., Lennerz, J. K., Mihm, M. C., Wargo, J. A., et al. (2012) · Nature · doi:10.1038/nature11624 · Cited by 497
Self-citationMaio, M., Grob, J.-J., Aamdal, S., Bondarenko, I., Robert, C., Thomas, L., Garbe, C., Chiarion-Sileni, V., Testori, A., Chen, T.-T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.6018 · Cited by 481
Self-citationGenetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
Tsao, H., Yang, G., Goel, V., Wu, H., & Haluska, F. G. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22243.x · Cited by 467
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Yu, F.-X., Luo, J., Mo, J.-S., Liu, G., Kim, Y. C., Meng, Z., Zhao, L., Peyman, G., Ouyang, H., Jiang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.017 · Cited by 463
Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
Epidemiology of invasive cutaneous melanoma
MacKie, R. M., Hauschild, A., & Eggermont, A. M. M. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp252 · Cited by 405
Self-citationPOT1 loss-of-function variants predispose to familial melanoma
Robles-Espinoza, C. D., Harland, M., Ramsay, A. J., Aoude, L. G., Quesada, V., Ding, Z., Pooley, K. A., Pritchard, A. L., Tiffen, J. C., Petljak, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2947 · Cited by 391
Oberholzer, P. A., Kee, D., Dziunycz, P., Sucker, A., Kamsukom, N., Jones, R., Roden, C., Chalk, C. J., Ardlie, K., Palescandolo, E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.7680 · Cited by 386
Self-citationRecent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385
Melanocortin‐1 receptor structure and functional regulation
García‐Borrón, J. C., Sánchez‐Laorden, B. L., & Jiménez‐Cervantes, C. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00278.x · Cited by 385
Burnet, N. G., Jefferies, S. J., Benson, R. J., Hunt, D. P., & Treasure, F. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602321 · Cited by 366
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Kwong, L. N., Costello, J. C., Liu, H., Jiang, S., Helms, T. L., Langsdorf, A. E., Jakubosky, D., Genovese, G., Muller, F. L., Jeong, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2941 · Cited by 358
From genes to drugs: targeted strategies for melanoma
Flaherty, K. T., Hodi, F. S., & Fisher, D. E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3218 · Cited by 354
Self-citationMC1R variants, melanoma and red hair color phenotype: A meta‐analysis
Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., & Fargnoli, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23396 · Cited by 349
Kvaal, K., Ulstein, I., Nordhus, I. H., & Engedal, K. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1330 · Cited by 349
The Surgeon General’s call to action to prevent skin cancer
Watson, M., Garnett, E., Guy, G. P., & Holman, D. M. (2014) · Cited by 332
Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment
Noonan, F. P., Zaidi, M. R., Wolnicka-Glubisz, A., Anver, M. R., Bahn, J., Wielgus, A., Cadet, J., Douki, T., Mouret, S., Tucker, M. A., et al. (2012) · Nature Communications · doi:10.1038/ncomms1893 · Cited by 331
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma
NCI DCEG Cancer Sequencing Working Group, Shi, J., Laboratory, N. D. C. G. R., French Familial Melanoma Study Group, Yang, X. R., Ballew, B., Rotunno, M., Calista, D., Fargnoli, M. C., Ghiorzo, P., et al. (2014) · Nature Genetics · doi:10.1038/ng.2941 · Cited by 331
Skin biopsy rates and incidence of melanoma: population based ecological study
Welch, H. G., Woloshin, S., & Schwartz, L. M. (2005) · BMJ · doi:10.1136/bmj.38516.649537.e0 · Cited by 330
A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
Rosenberg, S. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.116 · Cited by 312
Systematic skin cancer screening in Northern Germany
Breitbart, E. W., Waldmann, A., Nolte, S., Capellaro, M., Greinert, R., Volkmer, B., & Katalinic, A. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.11.016 · Cited by 302
Skin β-Endorphin Mediates Addiction to UV Light
Fell, G. L., Robinson, K. C., Mao, J., Woolf, C. J., & Fisher, D. E. (2014) · Cell · doi:10.1016/j.cell.2014.04.032 · Cited by 299
Self-citationRibas, A., Gonzalez, R., Pavlick, A., Hamid, O., Gajewski, T. F., Daud, A., Flaherty, L., Logan, T., Chmielowski, B., Lewis, K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70301-8 · Cited by 299
Self-citationHistone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Landreville, S., Agapova, O. A., Matatall, K. A., Kneass, Z. T., Onken, M. D., Lee, R. S., Bowcock, A. M., & Harbour, J. W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0946 · Cited by 289
Ives, N. J., Stowe, R. L., Lorigan, P., & Wheatley, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0253 · Cited by 284
Katalinic, A., Waldmann, A., Weinstock, M. A., Geller, A. C., Eisemann, N., Greinert, R., Volkmer, B., & Breitbart, E. (2012) · Cancer · doi:10.1002/cncr.27566 · Cited by 272
BRAF targeted therapy changes the treatment paradigm in melanoma
Ribas, A., & Flaherty, K. T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.69 · Cited by 271
Self-citationZimmer, L., Vaubel, J., Mohr, P., Hauschild, A., Utikal, J., Simon, J., Garbe, C., Herbst, R., Enk, A., Kämpgen, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118564 · Cited by 269
Self-citationThe Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
Sheppard, K. E., & McArthur, G. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0259 · Cited by 265
Self-citationTERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
Griewank, K. G., Murali, R., Puig-Butille, J. A., Schilling, B., Livingstone, E., Potrony, M., Carrera, C., Schimming, T., Möller, I., Schwamborn, M., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju246 · Cited by 254
Self-citationUltraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
Viros, A., Sanchez-Laorden, B., Pedersen, M., Furney, S. J., Rae, J., Hogan, K., Ejiama, S., Girotti, M. R., Cook, M., Dhomen, N., et al. (2014) · Nature · doi:10.1038/nature13298 · Cited by 249
Matsuoka, L. Y. (1988) · Archives of Dermatology · doi:10.1001/archderm.124.12.1802 · Cited by 247
Carli, P., De Giorgi, V., Crocetti, E., Mannone, F., Massi, D., Chiarugi, A., & Giannotti, B. (2004) · British Journal of Dermatology · doi:10.1111/j.0007-0963.2004.05860.x · Cited by 243
Marks, R. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.4.415 · Cited by 242
The Performance of MelaFind: A Prospective Multicenter Study
Monheit, G., Cognetta, A. B., Ferris, L., Rabinovitz, H., Gross, K., Martini, M., Grichnik, J. M., Mihm, M., Prieto, V. G., Googe, P., et al. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2010.302 · Cited by 231
Zimmer, L., Hillen, U., Livingstone, E., Lacouture, M. E., Busam, K., Carvajal, R. D., Egberts, F., Hauschild, A., Kashani-Sabet, M., Goldinger, S. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.1660 · Cited by 231
Self-citationSalerni, G., Carrera, C., Lovatto, L., Puig-Butille, J. A., Badenas, C., Plana, E., Puig, S., & Malvehy, J. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.008 · Cited by 228
Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center
Shoo, B. A., Sagebiel, R. W., & Kashani-Sabet, M. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.09.043 · Cited by 221
Identification of Clinically Featureless Incipient Melanoma Using Sequential Dermoscopy Imaging
Kittler, H., Guitera, P., Riedl, E., Avramidis, M., Teban, L., Fiebiger, M., Weger, R. A., Dawid, M., & Menzies, S. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.9.1113 · Cited by 220
Melanocytic Tumors of Uncertain Malignant Potential
Cerroni, L., Barnhill, R. L., Elder, D. E., Gottlieb, G. J., Heenan, P. J., Kutzner, H., LeBoit, P. E., Mihm, M. C., Rosaí, J., & Kerl, H. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf7fa0 · Cited by 220
Malvehy, J., Hauschild, A., Curiel‐Lewandrowski, C., Mohr, P., Hofmann‐Wellenhof, R., Motley, R., Berking, C., Grossman, D., Paoli, J., Loquai, C., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13121 · Cited by 210
Self-citationIn Vivo Reflectance Confocal Microscopy Enhances Secondary Evaluation of Melanocytic Lesions
Guitera, P., Pellacani, G., Longo, C., Seidenari, S., Avramidis, M., & Menzies, S. W. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.193 · Cited by 210
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
Chen, X., Wu, Q., Tan, L., Porter, D., Jager, M. J., Emery, C., & Bastian, B. C. (2014) · Oncogene · doi:10.1038/onc.2013.418 · Cited by 208
Carli, P., de Giorgi, V., Chiarugi, A., Nardini, P., Weinstock, M. A., Crocetti, E., Stante, M., & Giannotti, B. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.09.009 · Cited by 207
Accuracy in melanoma detection: A 10-year multicenter survey
Argenziano, G., Cerroni, L., Zalaudek, I., Staibano, S., Hofmann-Wellenhof, R., Arpaia, N., Bakos, R. M., Balme, B., Bandic, J., Bandelloni, R., et al. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.07.019 · Cited by 207
Self-citationBauer, J., & Bastian, B. C. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2005.00055.x · Cited by 204
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
Pellacani, G., Pepe, P., Casari, A., & Longo, C. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13148 · Cited by 197
Nathanson, K. L., Martin, A.-M., Wubbenhorst, B., Greshock, J., Letrero, R., D'Andrea, K., O'Day, S., Infante, J. R., Falchook, G. S., Arkenau, H.-T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0827 · Cited by 196
The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis
Colantonio, S., Bracken, M. B., & Beecker, J. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.11.050 · Cited by 195
Eggermont, A. M. M., Suciu, S., Testori, A., Kruit, W. H., Marsden, J., Punt, C. J., Santinami, M., Salès, F., Schadendorf, D., Patel, P., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.09.028 · Cited by 192
Self-citationJoosse, A., Collette, S., Suciu, S., Nijsten, T., Patel, P. M., Keilholz, U., Eggermont, A. M. M., Coebergh, J. W. W., & de Vries, E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5031 · Cited by 192
Joosse, A., Collette, S., Suciu, S., Nijsten, T., Lejeune, F., Kleeberg, U. R., Coebergh, J. W. W., Eggermont, A. M. M., & de Vries, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0584 · Cited by 189
The Genomic Landscape of Childhood and Adolescent Melanoma
Lu, C., Zhang, J., Nagahawatte, P., Easton, J., Lee, S., Liu, Z., Ding, L., Wyczalkowski, M. A., Valentine, M., Navid, F., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.425 · Cited by 186
Thomas, N. E., Kricker, A., Waxweiler, W. T., Dillon, P. M., Busam, K. J., From, L., Groben, P. A., Armstrong, B. K., Anton-Culver, H., Gruber, S. B., et al. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.1348 · Cited by 183
Screening for Skin Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-3-200902030-00008 · Cited by 181
Kelly, J. W., Yeatman, J. M., Regalia, C., Mason, G., & Henham, A. P. (1997) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138843.x · Cited by 164
Is Physician Detection Associated With Thinner Melanomas?
Epstein, D. S. (1999) · JAMA · doi:10.1001/jama.281.7.640 · Cited by 164
Melanoma metastasis: new concepts and evolving paradigms
Damsky, W. E., Theodosakis, N., & Bosenberg, M. (2014) · Oncogene · doi:10.1038/onc.2013.194 · Cited by 164
Melanoma Thickness Trends in the United States, 1988–2006
Criscione, V. D., & Weinstock, M. A. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.328 · Cited by 163
Whole genome sequencing of matched primary and metastatic acral melanomas
Turajlic, S., Furney, S. J., Lambros, M. B., Mitsopoulos, C., Kozarewa, I., Geyer, F. C., MacKay, A., Hakas, J., Zvelebil, M., Lord, C. J., et al. (2012) · Genome Research · doi:10.1101/gr.125591.111 · Cited by 163
BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
Matatall, K. A., Agapova, O. A., Onken, M. D., Worley, L. A., Bowcock, A. M., & Harbour, J. W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-371 · Cited by 159
Addiction to Indoor Tanning: Relation to Anxiety, Depression, and Substance Use
Mosher, C. E., & Danoff-Burg, S. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2009.385 · Cited by 158
Lodha, S., Saggar, S., Celebi, J. T., & Silvers, D. N. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00970.x · Cited by 156
Moloney, F. J., Guitera, P., Coates, E., Haass, N. K., Ho, K., Khoury, R., O'Connell, R. L., Raudonikis, L., Schmid, H., Mann, G. J., et al. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.514 · Cited by 148
Melanomas detected with the aid of total cutaneous photography
Feit, N. E., Dusza, S. W., & Marghoob, A. A. (2004) · British Journal of Dermatology · doi:10.1111/j.0007-0963.2004.05892.x · Cited by 146
Sentinel-Lymph-Node Biopsy for Cutaneous Melanoma
Gershenwald, J. E., & Ross, M. I. (2011) · New England Journal of Medicine · doi:10.1056/nejmct1002967 · Cited by 144
Self-citationHaenssle, H. A., Krueger, U., Vente, C., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700119 · Cited by 142
Developmental pathways activated in melanocytes and melanoma
Liu, J., Fukunaga‐Kalabis, M., Li, L., & Herlyn, M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.023 · Cited by 140
Self-citationPresentation and detection of invasive melanoma in a high-risk population
McPherson, M., Elwood, M., English, D. R., Baade, P. D., Youl, P., & Aitken, J. F. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.08.065 · Cited by 140
Roesch, A. (2014) · Oncogene · doi:10.1038/onc.2014.249 · Cited by 138
Self-citationMelanoma-induced immunosuppression and its neutralization
Umansky, V., & Sevko, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.003 · Cited by 138
The Melanoma Epidemic: Res Ipsa Loquitur
Beddingfield, F. C. (2003) · The Oncologist · doi:10.1634/theoncologist.8-5-459 · Cited by 138
Addictive-like behaviours to ultraviolet light among frequent indoor tanners
Harrington, C. R., Beswick, T. C., Leitenberger, J., Minhajuddin, A., Jacobe, H. T., & Adinoff, B. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2010.03882.x · Cited by 133
de Kock, I., Mirhosseini, M., Lau, F., Thai, V., Downing, M. G., Quan, H., Lesperance, M., & Yang, J. D. (2013) · Journal of Palliative Care · doi:10.1177/082585971302900305 · Cited by 119
Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A., & Gonzalez, R. C. (2009) · Cancer · doi:10.1002/cncr.24720 · Cited by 119
Self-citationMelanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry
Geller, A. C., Clapp, R., Sober, A. J., Gonsalves, L., Mueller, L., Christiansen, C. L., Shaikh, W. R., & Miller, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3728 · Cited by 118
Bottomley, A., Coens, C., Suciu, S., Santinami, M., Kruit, W., Testori, A., Marsden, J. R., Punt, C. J. A., Salès, F., Gore, M. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2069 · Cited by 115
Self-citationTargeting Oncogenic Drivers and the Immune System in Melanoma
McArthur, G. A., & Ribas, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5568 · Cited by 114
Self-citationKefford, R. F., Newton‐Bishop, J., Tucker, M. A., et al. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00894-x · Cited by 111
Corrie, P. G., Marshall, A., Dunn, J., Middleton, M. R., Nathan, P., Gore, M. E., Davidson, N. G. P., Nicholson, S., Kelly, C. G., Marples, M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70110-x · Cited by 108
de Vries, M., Hoekstra, H. J., & Hoekstra‐Weebers, J. E. H. M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0602-6 · Cited by 106
The Melanoma Epidemic: More Apparent Than Real?
Swerlick, R. A., & Chen, S. C. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.6.559 · Cited by 97
Tromme, I., Sacré, L., Hammouch, F., Legrand, C., Marot, L., Vereecken, P. M., Théate, I., van Eeckhout, P., Richez, P., Baurain, J. F., et al. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11042.x · Cited by 96
Spitz nevi and other Spitzoid lesions
Luo, S., Sepehr, A., & Tsao, H. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.040 · Cited by 85
Melanoma—the run of success continues
Schadendorf, D., & Hauschild, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.246 · Cited by 85
Self-citationGenetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects
Griewank, K., Scolyer, R. A., Thompson, J. F., Flaherty, K. T., Schadendorf, D., & Murali, R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt435 · Cited by 84
Self-citationResistance to RAF Inhibitors Revisited
Hartsough, E. J., Shao, Y., & Aplin, A. E. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.358 · Cited by 83
Statins, Fibrates, and Melanoma Risk: a Systematic Review and Meta-analysis
Freeman, S., Drake, A. L., Heilig, L. F., Graber, M., McNealy, K. M., Schilling, L. M., & Dellavalle, R. P. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj412 · Cited by 82
von Euw, E., Atefi, M. S., Attar, N., Chu, C., Zachariah, S., Burgess, B. L., Mok, S., Ng, C., Wong, D. J. L., Chmielowski, B., et al. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-22 · Cited by 80
Self-citationAnti-apoptotic proteins on guard of melanoma cell survival
Hartman, M. L., & Czyż, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.010 · Cited by 80
Goodson, A. G., Florell, S. R., Hyde, M. A., Bowen, G. M., & Grossman, D. (2010) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2010.01589.x · Cited by 80
Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia
Iannacone, M. R., Youlden, D. R., Baade, P. D., Aitken, J. F., & Green, A. C. (2014) · International Journal of Cancer · doi:10.1002/ijc.28956 · Cited by 78
Eggermont, A. M. M., Chiarion‐Sileni, V., Grob, J., Dummer, R., Wolchok, J. D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P. A., Richards, J. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.18_suppl.lba9008 · Cited by 77
Self-citationTelomerase Activity in Melanocytic Lesions
Rudolph, P., Schubert, C., Tamm, S., Heidorn, K., Hauschild, A., Michalska, I., Majewski, S., Krupp, G., Jabłońska, S., & Parwaresch, R. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65011-0 · Cited by 75
Self-citationImpact of Melanoma on Patients' Lives Among 562 Survivors: A Dutch Population-Based Study
Holterhues, C., Cornish, D., van de Poll-Franse, L. V., Krekels, G., Koedijk, F., Kuijpers, D., Coebergh, J. W. W., & Nijsten, T. E. C. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2010.433 · Cited by 73
The Complexity of Diagnosing Melanoma
Marghoob, A. A., & Scope, A. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.388 · Cited by 72
Flaherty, K. T., Hennig, M., Lee, S. J., Ascierto, P. A., Dummer, R., Eggermont, A. M. M., Hauschild, A., Kefford, R. F., Kirkwood, J. M., Long, G. V., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70007-5 · Cited by 72
Self-citationMelanoma: Clinical Features and Genomic InsightsPreprint
Hawryluk, E. B., & Tsao, H. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015388 · Cited by 69
Clinical germline genetic testing for melanoma.
Hansen, C. B., Wadge, L. M., Lowstuter, K. J., Boucher, K. M., & Leachman, S. A. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01469-x · Cited by 66
Germline melanoma susceptibility and prognostic genes: A review of the literature
Ward, K. A., Lazovich, D., & Hordinsky, M. K. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.02.042 · Cited by 64
Grob, J., Amonkar, M. M., Martín‐Algarra, S., Демидов, Л. В., Goodman, V. L., Grotzinger, K. M., Haney, P., Kämpgen, E., Karaszewska, B., Mauch, C., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu154 · Cited by 61
Self-citationHausauer, A. K., Swetter, S. M., Cockburn, M., & Clarke, C. A. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.44 · Cited by 59
Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials
Hamidou, Z., Dabakuyo‐Yonli, T. S., & Bonnetain, F. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.57 · Cited by 59
Schadendorf, D., Amonkar, M. M., Milhem, M. M., Grotzinger, K. R., Демидов, Л. В., Rutkowski, P. L., Garbe, C., Dummer, R., Hassel, J. C., Wolter, P., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt580 · Cited by 58
Self-citationCan statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials
Bonovas, S., Nikolopoulos, G. K., Filioussi, K., Peponi, E., Bagos, P. G., & Sitaras, N. M. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9396-x · Cited by 50
American college of preventive medicine policy statement: Screening for skin cancer
Ferrini, R. L., Perlman, M., & Hill, L. L. (1998) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(97)00007-x · Cited by 49
Hatswell, A. J., Pennington, B., Pericleous, L., Rowen, D., Lebmeier, M., & Lee, D. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0140-1 · Cited by 49
Downing, A., Yu, X. Q., Newton‐Bishop, J., & Forman, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23495 · Cited by 48
Progressive Increase in Telomerase Activity From Benign Melanocytic Conditions to Malignant Melanoma
Ramirez, R. D., D’Atri, S., Pagani, E., Faraggiana, T., Lacal, P. M., Taylor, R. S., & Shay, J. W. (1999) · Neoplasia · doi:10.1038/sj.neo.7900004 · Cited by 47
Gauging the Long-Term Benefits of Ipilimumab in Melanoma
Ribas, A., & Flaherty, K. T. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5041 · Cited by 47
Self-citation
Cited by
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Van Allen, E. M., Miao, D., Schilling, B., Shukla, S. A., Blank, C., Zimmer, L., Sucker, A., Hillen, U., Geukes Foppen, M. H., Goldinger, S. M., et al. (2015) · Science · doi:10.1126/science.aad0095 · Cited by 2,839
Self-citationPyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Signaling Pathways in Melanogenesis
D’Mello, S., Finlay, G., Baguley, B., & Askarian-Amiri, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071144 · Cited by 1,071
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Dammeijer, F., van Gulijk, M., Mulder, E. E., Lukkes, M., Klaase, L., van den Bosch, T., van Nimwegen, M., Lau, S. P., Latupeirissa, K., Schetters, S., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.001 · Cited by 695
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 571
Metadata
- Authors
- Schadendorf, D., Fisher, D. E., Garbe, C., Gershenwald, J. E., Grob, J.-J., Halpern, A., Herlyn, M., Marchetti, M. A., McArthur, G., Ribas, A., Roesch, A., & Hauschild, A.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-04-23
- Volume
- 1
- Issue
- 1
- Pages
- 15003-15003
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4210992847
- Cited by
- 613
- References
- 216
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.